Jefferies Cuts PT on AVEO Pharmaceuticals (AVEO); More Cautious on Tivo Approval
Tweet Send to a Friend
Jefferies lowered its price target on AVEO Pharmaceuticals (NASDAQ: AVEO) from $9 to $6 following the Q4 update. The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
